Page last updated: 2024-11-03

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Anesthesia

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Anesthesia in 2 studies

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.

Anesthesia: A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masaki, E1
Ebisawa, T1
Kondo, I1
Hayashida, K1
Matsumoto, Y1
Kawamura, M1
Shah, MK1
Kadowitz, PJ1

Other Studies

2 other studies available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Anesthesia

ArticleYear
P2-purinergic receptor antagonists reduce the minimum alveolar concentration of inhaled volatile anesthetics.
    Brain research, 2000, May-02, Volume: 864, Issue:1

    Topics: Adenosine Triphosphate; Anesthesia; Anesthetics, Inhalation; Animals; Antineoplastic Agents; Brain;

2000
Cyclic adenosine monophosphate-dependent vascular responses to purinergic agonists adenosine triphosphate and uridine triphosphate in the anesthetized mouse.
    Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:1

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine Triphosphate; Anesthesia; Animals; Blood Pressure; Cy

2002